Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $460.00 by Analysts at Morgan Stanley
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lowered by Morgan Stanley from $464.00 to $460.00 in a research note published on Friday morning,Benzinga reports. The brokerage currently has an equal weight rating on the pharmaceutical company’s stock. Several other research firms have also recently commented on VRTX. William Blair reissued an “outperform” […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lowered by Morgan Stanley from $464.00 to $460.00 in a research note published on Friday morning,Benzinga reports. The brokerage currently has an equal weight rating on the pharmaceutical company’s stock. Several other research firms have also recently commented on VRTX. William Blair reissued an “outperform” […]
